Opportunities for engineering outer membrane vesicles using synthetic biology approaches

Abstract

Gram-negative bacteria naturally shed lipid vesicles, which contain complex molecular cargoes, from their outer membrane. These outer membrane vesicles (OMVs) have important biological functions relating to microbial stress responses, microbiome regulation, and host-pathogen interactions. OMVs are also attractive vehicles for delivering drugs, vaccines, and other therapeutic agents because of their ability to interact with host cells and their natural immunogenic properties. OMVs are also set to have a positive impact on other biotechnological and medical applications including diagnostics, bioremediation, and metabolic engineering. We envision that the field of synthetic biology offers a compelling opportunity to further expand and accelerate the foundational research and downstream applications of OMVs in a range of applications including the provision of OMV-based healthcare technologies. In our opinion, we discuss how current and potential future synergies between OMV research and synthetic biology approaches might help to further accelerate OMV research and real-world applications for the benefit of animal and human health.

Keywords

Outer membrane vesicles / OMVs / synthetic biology / extracellular vesicles / therapeutics / diagnostics / vaccines / microbiology

References

[1] Schwechheimer C.Outer-membrane vesicles from gram-negative bacteria: biogenesis and functions.Nat Rev Microbiol2015;13:605-19 PMCID:PMC5308417

[2] Cecil JD,O'Brien-Simpson NM.Outer membrane vesicle-host cell interactions.Microbiol Spectr2019;7 PMCID:PMC6352913

[3] Toyofuku M,Eberl L.Types and origins of bacterial membrane vesicles.Nat Rev Microbiol2019;17:13-24

[4] Olsen I.Outer membrane vesicles - offensive weapons or good Samaritans?.J Oral Microbiol2015;7:27468 PMCID:PMC4385126

[5] Nagakubo T,Toyofuku M.Cracking open bacterial membrane vesicles.Front Microbiol2019;10:3026 PMCID:PMC6988826

[6] Brown L,Prados-Rosales R.Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi.Nat Rev Microbiol2015;13:620-30 PMCID:PMC4860279

[7] Huang Y,Chen W.Outer membrane vesicles (OMVs) enabled bio-applications: a critical review.Biotechnol Bioeng2022;119:34-47

[8] Wang S,Wang Z.Outer membrane vesicles for vaccination and targeted drug delivery.Wiley Interdiscip Rev Nanomed Nanobiotechnol2019;11:e1523 PMCID:PMC6203682

[9] Li Y,Qiu X.Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy.Bioact Mater2023;20:548-60 PMCID:PMC9253654

[10] Alexander LM.Modes of therapeutic delivery in synthetic microbiology.Trends Microbiol2023;31:197-211 PMCID:PMC9877134

[11] Alves NJ,Daniele MA.Bacterial nanobioreactors-directing enzyme packaging into bacterial outer membrane vesicles.ACS Appl Mater Interfaces2015;7:24963-72

[12] Yang D,Lee SY.Production of rainbow colorants by metabolically engineered escherichia coli.Adv Sci2021;8:e2100743 PMCID:PMC8261500

[13] Liu H,Su J.Engineered mammalian and bacterial extracellular vesicles as promising nanocarriers for targeted therapy.Extracell Vesicles Circ Nucleic Acids2022;3:63-86

[14] Hu R,Zhao Y.Exploiting bacterial outer membrane vesicles as a cross-protective vaccine candidate against avian pathogenic escherichia coli (APEC).Microb Cell Fact2020;19:119 PMCID:PMC7268718

[15] Zanella I,Tomasi M.Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform.J Extracell Vesicles2021;10:e12066

[16] Thapa HB,Camilli A.An intranasal vaccine based on outer membrane vesicles against SARS-CoV-2.Front Microbiol2021;12:752739 PMCID:PMC8602898

[17] Li R.Engineered bacterial outer membrane vesicles as multifunctional delivery platforms.Front Mater2020;7:202

[18] Kelwick R,Webb AJ.Developments in the tools and methodologies of synthetic biology.Front Bioeng Biotechnol2014;2:60 PMCID:PMC4244866

[19] Brooks SM.Applications, challenges, and needs for employing synthetic biology beyond the lab.Nat Commun2021;12:1390 PMCID:PMC7925609

[20] Voigt CA.Synthetic biology 2020-2030: six commercially-available products that are changing our world.Nat Commun2020;11:6379 PMCID:PMC7733420

[21] Liew FE,Abdalla T.Carbon-negative production of acetone and isopropanol by gas fermentation at industrial pilot scale.Nat Biotechnol2022;40:335-44

[22] Kelwick RJR,Freemont PS.Biological materials: the next frontier for cell-free synthetic biology.Front Bioeng Biotechnol2020;8:399 PMCID:PMC7235315

[23] El Karoui M,Fletcher L.Future trends in synthetic biology-a report.Front Bioeng Biotechnol2019;7:175

[24] Carbonell P,Robinson CJ.An automated design-build-test-learn pipeline for enhanced microbial production of fine chemicals.Commun Biol2018;1:66 PMCID:PMC6123781

[25] Opgenorth P,Okada T.Lessons from two design-build-test-learn cycles of dodecanol production in escherichia coli aided by machine learning.ACS Synth Biol2019;8:1337-51

[26] Casas A,Motraghi C.Removing the bottleneck: introducing cMatch - a lightweight tool for construct-matching in synthetic biology.Front Bioeng Biotechnol2021;9:785131 PMCID:PMC8784771

[27] Sanders LM,Yang JH.Biological research and self-driving labs in deep space supported by artificial intelligence.Nat Mach Intell2023;5:208-19

[28] Beal J,Myers C.The long journey towards standards for engineering biosystems: are the molecular biology and the biotech communities ready to standardise?.EMBO Rep2020;21:e50521 PMCID:PMC7202200

[29] Kelly JR,Davis JH.Measuring the activity of BioBrick promoters using an in vivo reference standard.J Biol Eng2009;3:4 PMCID:PMC2683166

[30] Théry C,Aikawa E.Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines.J Extracell Vesicles2018;7:1535750 PMCID:PMC6322352

[31] Dauros Singorenko P,Whitcombe A.Isolation of membrane vesicles from prokaryotes: a technical and biological comparison reveals heterogeneity.J Extracell Vesicles2017;6:1324731 PMCID:PMC5505020

[32] Jessop-Fabre MM.Improving reproducibility in synthetic biology.Front Bioeng Biotechnol2019;7:18 PMCID:PMC6378554

[33] Gilman J,Bandiera L.Statistical design of experiments for synthetic biology.ACS Synth Biol2021;10:1-18

[34] Beardall WAV,Dunlop MJ.Deep learning concepts and applications for synthetic biology.GEN Biotechnol2022;1:360-71 PMCID:PMC9428732

[35] Eastwood TA,Streather BR.High-yield vesicle-packaged recombinant protein production from E. coli.Cell Rep Methods2023;3:100396

[36] Tao S,Li N.The application of the CRISPR-cas system in antibiotic resistance.Infect Drug Resist2022;15:4155-68 PMCID:PMC9356603

[37] Porto EM,Slaymaker IM.Base editing: advances and therapeutic opportunities.Nat Rev Drug Discov2020;19:839-59 PMCID:PMC7721651

[38] Qi LS,Gilbert LA.Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression.Cell2013;152:1173-83 PMCID:PMC3664290

[39] Ceroni F,Furini S.Burden-driven feedback control of gene expression.Nat Methods2018;15:387-93

[40] Tian H,Xu T.Outer membrane vesicles derived from salmonella enterica serotype typhimurium can deliver shigella flexneri 2a O-polysaccharide antigen to prevent shigella flexneri 2a infection in mice.Appl Environ Microbiol2021;87:e0096821

[41] Gasperini G,Arato V.Salmonella paratyphi a outer membrane vesicles displaying vi polysaccharide as a multivalent vaccine against enteric fever.Infect Immun2021;89

[42] Plahar HA,Lane SD.Bioparts-a biological parts search portal and updates to the ICE parts registry software platform.ACS Synth Biol2021;10:2649-60

[43] Haines MC,Marshall J.Basicsynbio and the BASIC SEVA collection: software and vectors for an established DNA assembly method.Synth Biol2022;7:ysac023

[44] Kelwick RJR,Heliot A,Freemont PS.Opportunities to accelerate extracellular vesicle research with cell‐free synthetic biology.J of Extracellular Bio2023;2:e90

[45] Jumper J,Pritzel A.Highly accurate protein structure prediction with AlphaFold.Nature2021;596:583-9 PMCID:PMC8371605

[46] Lin Z,Rao R.Evolutionary-scale prediction of atomic-level protein structure with a language model.Science2023;379:1123-30

[47] Wang J,Juergens D.Scaffolding protein functional sites using deep learning.Science2022;377:387-94 PMCID:PMC9621694

[48] Dauparas J,Bennett N.Robust deep learning-based protein sequence design using ProteinMPNN.Science2022;378:49-56

[49] Zawada JF,Yin G.Cell-free technologies for biopharmaceutical research and production.Curr Opin Biotechnol2022;76:102719

[50] Dumas A,Spicer CD.Designing logical codon reassignment - Expanding the chemistry in biology.Chem Sci2015;6:50-69 PMCID:PMC5424465

[51] Young TS.Beyond the canonical 20 amino acids: expanding the genetic lexicon.J Biol Chem2010;285:11039-44 PMCID:PMC2856976

[52] Rezhdo A,Huang M.Future prospects for noncanonical amino acids in biological therapeutics.Curr Opin Biotechnol2019;60:168-78 PMCID:PMC6783319

[53] Duffy K,Holliger P.Modified nucleic acids: replication, evolution, and next-generation therapeutics.BMC Biol2020;18:112 PMCID:PMC7469316

[54] Xu C,Li M.Living material assembly of bacteriogenic protocells.Nature2022;609:1029-37

[55] Lussier F,Platzman I.Can bottom-up synthetic biology generate advanced drug-delivery systems?.Trends Biotechnol2021;39:445-59

[56] Chen C,Wang J.Active cargo loading into extracellular vesicles: Highlights the heterogeneous encapsulation behaviour.J Extracell Vesicles2021;10:e12163 PMCID:PMC8558234

[57] Chen H,Zeng Y.Recent advances in biomedical applications of bacterial outer membrane vesicles.J Mater Chem B2022;10:7384-96

[58] Michel LV.Outer membrane vesicles as molecular biomarkers for Gram-negative sepsis: Taking advantage of nature's perfect packages.J Biol Chem2022;298:102483 PMCID:PMC9576880